• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮质激素疗法对支气管肺发育不良的早期心血管影响]

[Early cardiovascular effects of corticotherapy for bronchopulmonary dysplasia].

作者信息

Lenclen R, Karam T, Gajdos V, Mourdie J, Hoenn E, Campot K, Paupe A

机构信息

Centre hospitalier intercommunal poissy-Saint-Germain, Site de poissy, 10, rue du Champ-Gaillard, 78300 Poissy, France.

出版信息

Arch Pediatr. 2001 Jan;8(1):32-8. doi: 10.1016/s0929-693x(00)00163-9.

DOI:10.1016/s0929-693x(00)00163-9
PMID:11218581
Abstract

OBJECTIVES

The aim of this study was to analyze the time course of cardiovascular effects in glucocorticoid-treated premature infants with bronchopulmonary dysplasia (BPD).

METHODS

In a retrospective case study, 63 ventilator-dependent very-low-birth-weight neonates (mean gestational age = 27.9 +/- 2 weeks and mean birth weight = 920 +/- 275 g) treated with dexamethasone (52%) or betamethasone (48%) were studied. The average value for each study day was calculated for systolic arterial blood pressure and heart rate.

RESULTS

At initiation of treatment, blood pressures increased significantly from pre-treatment to day 1 and continued to increase during the first week: as a percentage of pre-treatment baseline the mean increase for systolic arterial blood pressure was 19% (95% confidence interval [CI] = 16, 22) on day 2 (P < 0.001). The maximum amplitude of variation was observed before day 2 for 75% of the study group. As a group as a whole, the heart rate value significantly decreased on day 1 (mean difference = -14.6 beats/min; 95% CI = -16.5, -12.6; P < 0.001), and then reached pre-treatment value within one week. Cardiovascular response was independent of gestational age, birth weight and postnatal age at the beginning of treatment.

CONCLUSION

During postnatal steroid therapy a rise in blood pressure is a common side effect, but bradycardia is mentioned very occasionally. The present study shows a marked increase in blood pressure during the first 48 hours concomitant with a decrease in heart rate. The inverse relationship between systolic arterial blood pressure and heart rate suggests a baroreflex response.

摘要

目的

本研究旨在分析糖皮质激素治疗支气管肺发育不良(BPD)的早产婴儿心血管效应的时间进程。

方法

在一项回顾性病例研究中,对63例依赖呼吸机的极低出生体重儿(平均胎龄=27.9±2周,平均出生体重=920±275g)进行了研究,这些患儿接受了地塞米松(52%)或倍他米松(48%)治疗。计算每个研究日收缩动脉血压和心率的平均值。

结果

治疗开始时,血压从治疗前到第1天显著升高,并在第一周持续升高:作为治疗前基线的百分比,收缩动脉血压在第2天的平均升高为19%(95%置信区间[CI]=16,22)(P<0.001)。75%的研究组在第2天之前观察到最大变化幅度。作为一个整体组,心率值在第1天显著下降(平均差异=-14.6次/分钟;95%CI=-16.5,-12.6;P<0.001),然后在一周内恢复到治疗前值。心血管反应与治疗开始时的胎龄、出生体重和出生后年龄无关。

结论

产后类固醇治疗期间血压升高是常见的副作用,但心动过缓很少被提及。本研究显示在最初48小时内血压显著升高,同时心率下降。收缩动脉血压与心率之间的反比关系提示压力反射反应。

相似文献

1
[Early cardiovascular effects of corticotherapy for bronchopulmonary dysplasia].[皮质激素疗法对支气管肺发育不良的早期心血管影响]
Arch Pediatr. 2001 Jan;8(1):32-8. doi: 10.1016/s0929-693x(00)00163-9.
2
Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
J Pediatr. 1997 Apr;130(4):594-602. doi: 10.1016/s0022-3476(97)70244-0.
3
Pharmacokinetics of dexamethasone in premature neonates.地塞米松在早产儿中的药代动力学
Eur J Clin Pharmacol. 1996;49(6):477-83. doi: 10.1007/BF00195934.
4
[The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].[早产儿使用产后皮质类固醇疗法预防或治疗支气管肺发育不良:现状与建议]
Arch Pediatr. 2010 Oct;17(10):1480-7. doi: 10.1016/j.arcped.2010.07.013. Epub 2010 Sep 22.
5
[Glucocorticoide therapy in premature infants: French practices in 2006].[早产儿的糖皮质激素治疗:2006年法国的实践情况]
Arch Pediatr. 2009 Jul;16(7):999-1004. doi: 10.1016/j.arcped.2009.03.013. Epub 2009 May 1.
6
Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.支气管肺发育不良中的维生素A状况与产后地塞米松治疗
Pediatrics. 2000 Sep;106(3):547-53. doi: 10.1542/peds.106.3.547.
7
Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.支气管肺发育不良早产儿出生后使用倍他米松与地塞米松的比较:一项初步研究
J Perinatol. 2009 Apr;29(4):297-304. doi: 10.1038/jp.2008.194. Epub 2008 Dec 4.
8
A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.地塞米松预防接受表面活性剂治疗婴儿支气管肺发育不良的对照试验。
Pediatrics. 1996 Aug;98(2 Pt 1):204-10.
9
Postnatal steroids in extremely low birth weight infants: betamethasone or hydrocortisone?极低出生体重儿的产后类固醇:倍他米松还是氢化可的松?
Acta Paediatr. 2013 Jul;102(7):689-94. doi: 10.1111/apa.12255. Epub 2013 Apr 29.
10
Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.政策声明——产后皮质类固醇预防或治疗支气管肺发育不良。
Pediatrics. 2010 Oct;126(4):800-8. doi: 10.1542/peds.2010-1534. Epub 2010 Sep 6.

引用本文的文献

1
Hemodynamic consequences of respiratory interventions in preterm infants.早产儿呼吸干预的血液动力学后果。
J Perinatol. 2022 Sep;42(9):1153-1160. doi: 10.1038/s41372-022-01422-5. Epub 2022 Jun 11.